Anti-CD20 antibody treatment in refractory Class IV lupus nephritis

Nephrol Dial Transplant. 2007 Jan;22(1):291-3. doi: 10.1093/ndt/gfl501. Epub 2006 Nov 9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20 / chemistry*
  • Antigens, CD20 / immunology*
  • Antineoplastic Agents / therapeutic use
  • Azathioprine / pharmacology
  • Cyclophosphamide / pharmacology
  • Cyclosporine / pharmacology
  • Female
  • Humans
  • Lupus Nephritis / immunology*
  • Lupus Nephritis / metabolism*
  • Lupus Nephritis / therapy*
  • Male
  • Mycophenolic Acid / analogs & derivatives
  • Mycophenolic Acid / pharmacology
  • Nephritis
  • Rituximab
  • Treatment Outcome

Substances

  • Antibodies
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Antineoplastic Agents
  • Rituximab
  • Cyclosporine
  • Cyclophosphamide
  • Mycophenolic Acid
  • Azathioprine